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INTRODUCTION:
•

Currently, there are very few drugs available to treat Alzheimer's diseaseand
these drugs do not reverse or stop the disease from progressing. Many of them
work by inhibiting acetylcholinesterase, which only moderately helps maintain
cholinergic nerve function but does not stop neuronal death.

•

GSK-3β is an enzyme that phosphorylates tau proteins in the brain. If tau proteins
become hyperphosphorylated, they break apart and aggregate, forming the
neurotoxic tau tangles that lead to Alzheimer's Disease. In theory, inhibition of
GSK-3β will prevent neurotoxic tangles that cause cholinergic neuron death.

•

Our purpose was to identify new GSK-3β inhibitors from plant sources. Potent
natural inhibitors could make it possible to take dietary supplements or eat
certain foods to decrease the risk of developing Alzheimer's Disease.

METHODS
1.
•
•

Ligand Screening
Compounds known to inhibit GSK-3β were identified using PubChem.
A database of herbal compounds was screened using computer modeling to
identify natural products structurally like known GSK-3β inhibitors.

2. Compound Testing
•
Identified compounds were purchased and dissolved in 10% DMSO.
•
Compounds were tested at a concentration of 100 µM in a 96 well plate with
active GSK-3β enzyme and ATP.
•
Negative control wells (no enzyme) and positive control wells (no inhibitors) were
included on the plate, along with wells containing known GSK-3β inhibitors like
quercetin and luteolin.
•
Kinase-Glo® Plus was used to measure enzyme activity in each well. This reagent
luminesces in proportion to the amount of ATP in the well.
•
More enzyme inhibition = more unused ATP = more luminescence
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•

•

Compounds from the flavanone class of flavonoids, found primarily in citrus,
inhibited GSK-3β with potencies that varied based on their stereochemistry and
arrangement of alcohol groups.
S-Eriodictyol rivaled some known flavonoid inhibitors in its potency.

BOTTOM LINE
The structural basis for GSK-3β inhibition by a series of
citrus flavanones was identified.
However, currently known flavonoids from foods are
unlikely to inhibit GSK -3β in vivo because of their
inadequate potency and rapid metabolism.
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